Goldman Says Covid-19 Vaccine Approval Could Upend Markets
Goldman Sachs Group Inc. signage is displayed on the floor of the New York Stock Exchange in New York, U.S. (Photographer: Jin Lee/Bloomberg)

Goldman Says Covid-19 Vaccine Approval Could Upend Markets

(Bloomberg) -- Investors should consider the risk of a successful coronavirus vaccine unsettling markets by sparking a sell-off in bonds and rotation out of technology into cyclical stocks, accordi...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.